|
|
||||||||
The FASEB Journal, Vol 11, 314-321, Copyright © 1997 by The Federation of American Societies for Experimental Biology
REVIEWS |
H Glatt
German Institute of Human Nutrition, Potsdam-Rehbrucke.
Sulfation is a common final step in the biotransformation of xenobiotics and is traditionally associated with inactivation. However, the sulfate group is electron-withdrawing and may be cleaved off heterolytically in some molecules, leading to an electrophilic cation. The stable heterologous expression of sulfotransferases in indicator cells of standard mutagenicity tests has substantially improved the accessibility of this activation pathway. Sulfotransferase-mediated genotoxic effects have been demonstrated for numerous benzylic alcohols derived from polycyclic aromatic hydrocarbons and various aromatic hydroxylamines. Also, hycanthone (a benzylic alcohol), alpha- hydroxytamoxifen (an allylic alcohol), 1'-hydroxysafrole (an allylic/benzylic alcohol), and 2-nitropropane are activated to genotoxicants by sulfotransferases. Various reactive sulfate conjugates show strong mutagenic effects only when they are generated directly within the indicator cell, due to their inefficient penetration of cell membranes. In other cases, secondary membrane-penetrating reactive species are formed from sulfuric acid esters by displacement reactions with medium components, such as chloride or amino acids. Reaction with water regenerates the alcohol, which becomes available for a new cycle of activation. Different sulfotransferases from the same species as well as related forms from rat and human differ in their substrate specificities and tissue distributions. These characteristics and reactivities of the sulfate conjugates formed may explain organotropic effects of the compounds activated via sulfotransferases.
This article has been cited by other articles:
![]() |
H. Suzuki, J. S. Morris, Y. Li, M. A. Doll, D. W. Hein, J. Liu, L. Jiao, M. M. Hassan, R. S. Day, M. L. Bondy, et al. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer Carcinogenesis, June 1, 2008; 29(6): 1184 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Lu, Y.-C. Hsieh, M.-Y. Liu, Y.-H. Lin, C.-J. Chen, and Y.-S. Yang Identification and Characterization of Two Amino Acids Critical for the Substrate Inhibition of Human Dehydroepiandrosterone Sulfotransferase (SULT2A1) Mol. Pharmacol., March 1, 2008; 73(3): 660 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Meinl, B. Ebert, H. Glatt, and A. Lampen Sulfotransferase Forms Expressed in Human Intestinal Caco-2 and TC7 Cells at Varying Stages of Differentiation and Role in Benzo[a]pyrene Metabolism Drug Metab. Dispos., February 1, 2008; 36(2): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. U. Gamage, S. Tsvetanov, R. G. Duggleby, M. E. McManus, and J. L. Martin The Structure of Human SULT1A1 Crystallized with Estradiol: AN INSIGHT INTO ACTIVE SITE PLASTICITY AND SUBSTRATE INHIBITION WITH MULTI-RING SUBSTRATES J. Biol. Chem., December 16, 2005; 280(50): 41482 - 41486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. S. Saini, J. Sonoda, L. Xu, D. Toma, H. Uppal, Y. Mu, S. Ren, D. D. Moore, R. M. Evans, and W. Xie A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification Mol. Pharmacol., February 1, 2004; 65(2): 292 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sheng and M. W. Duffel ENANTIOSELECTIVITY OF HUMAN HYDROXYSTEROID SULFOTRANSFERASE ST2A3 WITH NAPHTHYL-1-ETHANOLS Drug Metab. Dispos., June 1, 2003; 31(6): 697 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. U. Gamage, R. G. Duggleby, A. C. Barnett, M. Tresillian, C. F. Latham, N. E. Liyou, M. E. McManus, and J. L. Martin Structure of a Human Carcinogen-converting Enzyme, SULT1A1. STRUCTURAL AND KINETIC IMPLICATIONS OF SUBSTRATE INHIBITION J. Biol. Chem., February 21, 2003; 278(9): 7655 - 7662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cronin, S. Mowbray, H. Durk, S. Homburg, I. Fleming, B. Fisslthaler, F. Oesch, and M. Arand The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase PNAS, February 18, 2003; 100(4): 1552 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chapman, M. C. Bryan, and C.-H. Wong Mechanistic studies of beta -arylsulfotransferase IV PNAS, February 4, 2003; 100(3): 910 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Markovich Physiological Roles and Regulation of Mammalian Sulfate Transporters Physiol Rev, October 1, 2001; 81(4): 1499 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. H. Coughtrie and L. E. Johnston Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528. [Abstract] [Full Text] |
||||
![]() |
W. Zheng, D. Xie, J. R. Cerhan, T. A. Sellers, W. Wen, and A. R. Folsom Sulfotransferase 1A1 Polymorphism, Endogenous Estrogen Exposure, Well-done Meat Intake, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 89 - 94. [Abstract] [Full Text] |
||||
![]() |
J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Seth, K. L. Lunetta, D. W. Bell, H. Gray, S. M. Nasser, E. Rhei, C. M. Kaelin, D. J. Iglehart, J. R. Marks, J. E. Garber, et al. Phenol Sulfotransferases: Hormonal Regulation, Polymorphism, and Age of Onset of Breast Cancer Cancer Res., December 1, 2000; 60(24): 6859 - 6863. [Abstract] [Full Text] |
||||
![]() |
R. Dajani, A. Cleasby, M. Neu, A. J. Wonacott, H. Jhoti, A. M. Hood, S. Modi, A. Hersey, J. Taskinen, R. M. Cooke, et al. X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3. MOLECULAR MODELING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS DEMONSTRATE A MOLECULAR BASIS FOR SULFOTRANSFERASE SUBSTRATE SPECIFICITY J. Biol. Chem., December 31, 1999; 274(53): 37862 - 37868. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Engst, R. Landsiedel, H. Hermersdorfer, J. Doehmer, and H. Glatt Benzylic hydroxylation of 1-methylpyrene and 1-ethylpyrene by human and rat cytochromes P450 individually expressed in V79 Chinese hamster cells Carcinogenesis, September 1, 1999; 20(9): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakakibara, K. Yanagisawa, J. Katafuchi, D. P. Ringer, Y. Takami, T. Nakayama, M. Suiko, and M.-C. Liu Molecular Cloning, Expression, and Characterization of Novel Human SULT1C Sulfotransferases That Catalyze the Sulfonation of N-Hydroxy-2-acetylaminofluorene J. Biol. Chem., December 18, 1998; 273(51): 33929 - 33935. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kakuta, E. V. Petrotchenko, L. C. Pedersen, and M. Negishi The Sulfuryl Transfer Mechanism. CRYSTAL STRUCTURE OF A VANADATE COMPLEX OF ESTROGEN SULFOTRANSFERASE AND MUTATIONAL ANALYSIS J. Biol. Chem., October 16, 1998; 273(42): 27325 - 27330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Song, M. H. Jung, S. C. Kim, T. Hassan, A. K. Roy, and B. Chatterjee Tissue-specific and Androgen-repressible Regulation of the Rat Dehydroepiandrosterone Sulfotransferase Gene Promoter J. Biol. Chem., August 21, 1998; 273(34): 21856 - 21866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Pothuluri, J. B. Sutherland, J. P. Freeman, and C. E. Cerniglia Fungal Biotransformation of 6-Nitrochrysene Appl. Envir. Microbiol., August 1, 1998; 64(8): 3106 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Banoglu and M. W. Duffel Studies on the Interactions of Chiral Secondary Alcohols with Rat Hydroxysteroid Sulfotransferase STa Drug Metab. Dispos., November 1, 1997; 25(11): 1304 - 1310. [Abstract] [Full Text] |
||||
![]() |
M. Takahashi, N. Tsuboyama-Kasaoka, T. Nakatani, M. Ishii, S. Tsutsumi, H. Aburatani, and O. Ezaki Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G338 - G348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |